Podcasts about Gaillard

"The Lust of the Flesh" Pastor Brad Gaillard May 18, 2025 by Tuscaloosa First Assembly

Le conflit entre la Russie et l'Ukraine a montré le rôle primordial de l'artillerie pour frapper loin de la ligne de front en l'absence de maîtrise ciel. L'armée française fait le constat qu'elle doit rapidement se doter de systèmes d'artillerie à longue portée. Car les systèmes qui équipent les forces seront bientôt obsolètes, pointe une mission d'information menée par l'Assemblée nationale. Un trou capacitaire est à redouter, disent les députés. Jusqu'à présent, les feux dans la profondeur étaient l'apanage de l'armée de l'Air. Grâce à leurs missiles de croisières, les chasseurs bombardiers avaient pour mission d'attaquer les cibles stratégiques, à plusieurs centaines de kilomètres derrière les lignes ennemies. Mais la démocratisation des défenses antiaériennes, fait planer un véritable doute sur les chances de l'aviation à pouvoir franchir les bulles de déni d'accès. Pour s'affranchir de ces barrières, l'artillerie roquette est donc redevenue centrale, souligne Vincent Tourret, chercheur à l'Université de Montréal : « On a besoin à la fois d'une puissance de feu dans la profondeur qui ne soit pas aérienne, mais en plus de ça, on a besoin d'une puissance de feu qui soit en fait beaucoup plus cheap, ou du moins qui a des effets de neutralisation qui sont plus vastes. Tout notre modèle quand même depuis la guerre froide, c'est comment on arrête des chars russes. On passe là, de trois ou quatre cibles bien identifiées, à une centaine de fantassins qui courent dans tous les et sens ou qui circulent sur des motos ! Jamais on aura le volume de feu pour traiter ça ! Et donc c'est pour ça qu'on revient à une logique roquette »Foudre, un système proposé par Turgis et GaillardArmé par le 1er Régiment d'Artillerie de Belfort, les 9 derniers systèmes LRU (pour lances roquettes unitaires), arriveront en fin de vie en 2027. Ce trou capacitaire, Turgis et Gaillard l'a identifié il y a deux ans. En mode agile, cette entreprise de taille intermédiaire, vient donc proposer un système appelé Foudre : c'est-à-dire un châssis, un panier de guidage et un système de conduite de tir capable de recevoir tous les missiles existants de 75 à 1000 kilomètres de portée. L'entreprise s'est déjà fait remarquer avec l'Aarok, un prototype de drone de reconnaissance et d'attaque longue distance, rappelle la présidente de l'entreprise, Fanny Turgis. « On a une capacité à effectivement fabriquer rapidement les choses, mais ça, c'est inhérent à la configuration de notre société. On a des capacités qui sont duales, du personnel civil qui peut aller vers le militaire et nous on était déjà prêt il y a quelques années à cette économie de guerre. On est à l'avant-garde du combat connecté, donc en présentant, à la fois notre drone Aarok et également ce lance-roquettes qui est sorti très rapidement, on veut démontrer qu'on a la capacité de pouvoir faire de la reconnaissance avec un système aérien, et de la frappe dans la profondeur et que toutes ces plateformes peuvent communiquer entre elles. » À lire aussiL'armée de terre française à l'heure de la guerre totaleDeux consortiums, Safran-MBDA d'un côté et Thales-Arianegroup de l'autre, développent également des projets de systèmes d'artillerie roquette.Les drones d'attaque longue portée comme alternativeMais les premiers tirs de démonstration n'auront lieu que l'an prochain, et si l'un des projets n'aboutit pas, à un coût raisonnable, les armées seront contraintes d'acheter ce matériel sur étagère, à l'étranger, alerte le député Jean-Louis Thiériot, « Ce dont il faut bien se rendre compte, c'est qu'aujourd'hui, on a un 'time to market' avant de mise sur le marché qui n'est pas bon puisque la plupart des pays européens ont déjà passé des commandes, que ce soit d'HIMARS américain, de PULS israélien ou encore les Polonais qui ont acheté coréen.Ça veut dire que les chances de succès commercial sont limitées. Donc il faut vraiment se poser la question : qu'est-ce qui est stratégique ? C'est d'être capable de produire de la roquette sur le territoire national, éventuellement sous licence et qu'est-ce qu'il l'est moins ? C'est le châssis, le panier, la conduite de tirs à partir du moment où elle est interopérable puisque ça, il n'y a aucun saut technologique dedans. » La roquette n'est pas non plus l'alpha et l'omega de l'artillerie longue portée, souligne Vincent Tourret et le chercheur de rappeler qu'en Ukraine, les drones d'attaque longue distance ont prouvé leur efficacité à moindre coût.

Mother's Day "The Unseen Sacrifices" Sermon Pastor Brad Gaillard May 11, 2025 by Tuscaloosa First Assembly

C'est quoi être aligné ? Est-ce vraiment si important pour être heureux ? Et comment réussir à l'être tout en gérant les réalités du quotidien ?Diane accompagne des entrepreneurs sur leur santé mentale et leur alignement. Elle est également experte en prise de parole et coach pitch chez QVEMA. Elle répond à toutes ces questions durant ce riche épisode !Avec Clément Dubois, elle parle d'alignement, de santé mentale, d'écriture, de relations toxiques, et de l'importance de bouger pour aller mieux. Un échange sans filtre, nourri d'expériences concrètes et de conseils utiles pour retrouver sens et équilibre.

In this episode, we follow one Scott Gaillard's real-world journey from curious beginner to accomplished deer tracker. Through raw stories, hard lessons, and insights from seasoned hunters, this episode dives into the diverse journey by which hunters find their ways to the big woods. Whether you're a seasoned outdoorsman or just setting out, join the adventure one story at a time! Enjoy!#deertracking #deerhunting #getoutsideitsgoodforthesoul

"The Second Chance" (John 21 1-19) Pastor Brad Gaillard April 27, 2025 by Tuscaloosa First Assembly

PASSION8 "The Crucifixion" Pastor Brad Gaillard April 13, 2025 by Tuscaloosa First Assembly

PASSION8 "The Empty Tomb" Pastor Brad Gaillard April 20, 2025 by Tuscaloosa First Assembly

Allison is the host of the Run Your Story Podcast. She's awesomsauce 3000. Enjoy.This episode is honored to be sponsored byRunNTri.com - THEY'RE back baby!

For our ‘Editor Expertise' series, we will be meeting with each of our Senior Editors, who will share the reason they went into animal ecology, their current and future research focus, and their experience working as an editor for the Journal of Animal Ecology. Our aim is to spread awareness of their research area and give you a chance to get to know the editors behind the journal. This month's guest is Professor Jean-Michel Gaillard, Senior Editor for the Journal of Animal Ecology. (0:00) – British Ecological Society intro (0:33) – Podcast introduction (01:15) – Jean-Michel's journey into animal ecology (02:58) – Jean-Michel's current and future research focus (07:20) – Shoutouts to past supervisors and colleagues (08:50) – Jean-Michel's experience as Senior Editor for the Journal of Animal Ecology (12:40) – Jean-Michel's editorial highlights and challenges during his time with the journal (15:40) – Advice for people who want to become editors / are thinking of a career in ecology (17:32) – British Ecological Society outro

PASSION8 "The Last Night" Pastor Brad Gaillard April 6, 2025 by Tuscaloosa First Assembly

Guests: Erwin Dekker (George Mason University), Charles Rose (PhD from King's College London), Carlos Eduardo Suprinyak (The American University of Paris), Pedro G. Duarte (Insper), Ariane Dupont Kieffer (Université Paris 1), Luca Timponelli (Centre Walras Pareto, Unil), María Gutiérrez Ruan (Centre Walras Pareto, Unil), Elizaveta Burina (Université Paris 1), Léa Lakjaa (Université de Reims), Adèle Gaillard, (PHARE, Université Panthéon Sorbonne), Steven Medema (Duke University), Marianne Johnson (University of Wisconsin Oshkosh) Host and Producer: Maria Bach (Centre Walras-Pareto, University of Lausanne) Based on almost 2 years of interviews with current and former PhD students, supervisors along with lots and lots of conversations on supervision, I offer you a series of episodes on supervision. In the first episode, I explore a series of critical "don'ts" that both PhD students and their supervisors should be aware of to ensure a healthier, more productive PhD journey. In this second episode, I offer up lots of solutions or rather the dos of supervision. Then there will be an episode on all the cases where it's not clear what the best solution is, or the solution is rather different depending on context: I am calling them the in-betweens. In a fourth episode I will be talking to a sort of PhD coach, who has lots of experience with supervising and thinking about supervision. A final short episode will offer us a list of 10 key things that supervisors and PhD students need – the 10 commandments of supervision, if you will. The Dos of Supervision Establishing Basic Foundations of Support Building Trust and Structure Supporting Intellectual Growth and Independence Tools and Organization for Success Advanced Guidance on Research and Focus Dealing with Challenges and Growth in the Process Ongoing Support Building a Sense of Belonging and Integration Dealing with Tough Situations and Navigating Change Featured music (apart from the usual intro and outro music): Awakening (loop ver.3) by AudioCoffee -- https://freesound.org/s/762743/ -- License: Attribution NonCommercial 4.0

Pull up a chair in camp with Hal and Lee and watch this episode on YouTube! https://youtu.be/nSTiwpDusJY Hal and Lee sit down with Scott to talk about becoming a big woods hunter, the peak and decline of the 7600, upcoming BWB videos and more on this episode of the podcast. Check out Scott's 2024 Maine hunt here: https://youtu.be/Snlupw1gqtA  

"Déclaration des droits de la femme et de la citoyenne" aux éditions Flammarion. Entretien avec Aurélia Gaillard.Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

PASSION8 "Fig Tree and Temple Cleansing" Pastor Brad Gaillard March 30, 2025 by Tuscaloosa First Assembly

PASSION8 "The Triumphal Entry" Pastor Brad Gaillard March 23, 2025 by Tuscaloosa First Assembly

Tenure of Office: November 25, 1814 - March 3, 1817 With the death of VP Elbridge Gerry, the Senate had to choose someone from their ranks who could preside over them so that they could carry out business for the next two and a half years. Luckily, they knew a guy who was already familiar with the view from the rostrum. Join us to learn more about John Gaillard of South Carolina's rise in politics and what he got up to in his lengthy tenure as President Pro Tem. Sources used for this episode can be found at https://www.presidenciespodcast.com. Learn more about your ad choices. Visit megaphone.fm/adchoices

Sabino Maria Frassà"Il Braille Stellato di Fulvio Morella"Il 2025 è l'anno del Braille Stellato, l'alfabeto ideato da Fulvio Morella per celebrare il bicentenario del sistema di scrittura utilizzato dalle persone cieche e ipovedenti. Il Braille Stellato, ideato da Fulvio Morella nel 2022, è un innovativo alfabeto visivo-tattile che trasforma il linguaggio braille in un codice estetico ispirato alle costellazioni. I punti braille vengono sostituiti da stelle, dando vita a un cielo stellato in cui è possibile leggere e toccare enigmatici messaggi celesti. Da Freud a San Francesco, da Pierangelo Bertoli a Seneca, tutto l'immaginario dell'artista prende forma attraverso costellazioni che si fanno parole. Questo sistema rivoluziona la scrittura braille, unendo percezione tattile ed esperienza visiva, trasformando ogni opera in un intreccio di arte, inclusione e narrazione. Il risultato è una scrittura che non è solo un mezzo di comunicazione, ma anche una forma di espressione poetica e universale.Questo innovativo linguaggio tattile ed estetico, concepito dall'artista valtellinese classe 1971 e promosso per primo da Cramum, ha ottenuto un crescente riconoscimento da parte di istituzioni e collezioni di prestigio internazionale. Le opere di Morella sono entrate a far parte di raccolte di rilievo, tra cui il Museo del Braille di Milano, il Museo del Braille di Parigi, la Zecca Italiana, il Kunsthistorisches Museum di Vienna, la Monnaie de Paris e l'UNESCO di Parigi. Il valore del suo lavoro è stato consacrato con la vittoria del Premio alla Carriera Alfredo d'Andrade 2023 e la selezione per importanti eventi artistici e medaglie ufficiali. "Con il suo alfabeto stellato, Morella invita il pubblico a toccare il cielo con le dita, trasformando l'arte in un'esperienza tanto evocativa quanto sensoriale e inclusiva", spiega Sabino Maria Frassà, direttore creativo di Cramum.Il Braille Stellato rappresenta una nuova frontiera dell'arte multisensoriale, in cui la bellezza diventa accessibile a tutti, abbattendo barriere percettive e culturali. "Le opere di Morella nascono con l'obiettivo di essere universali, superando i limiti della percezione e rendendo l'arte un'esperienza condivisa e senza confini", aggiunge ancora Frassà. Attraverso il suo linguaggio universale, Morella ci ricorda che i limiti sono solo traguardi da superare con ingegno e sensibilità, trasformando ogni opera in un ponte tra emozione e conoscenza.Il braille stellato e le OlimpiadiL'innovazione del Braille Stellato ha portato alla selezione delle opere di Fulvio Morella per la realizzazione di prestigiosi riconoscimenti internazionali. In particolare, la Medaglia "Ailes de Mouette" per le Olimpiadi e Paralimpiadi di Parigi 2024: un omaggio al superamento dei limiti e alla resilienza, presentata presso l'INJA Louis Braille di Parigi. "Il Braille, da 200 anni, è uno strumento straordinario che abbatte le barriere, rendendo le persone cieche e ipovedenti parte pulsante e attiva della società," afferma Stéphane Gaillard, direttore dell'INJA Louis Braille.Dopo questo successo, l'artista è stato selezionato dal Comitato Italiano Paralimpico (CIP) e dall'Unione Stampa Sportiva Italiana (USSI) per elaborare la medaglia della prima edizione del Premio CIP-USSI, un riconoscimento assegnato a giornalisti e comunicatori che hanno saputo raccontare lo sport paralimpico con passione e dedizione. È nata così la medaglia "Raccontami", ispirata al proemio dell'Odissea, che invita alla riflessione sul valore della narrazione. "Ogni eroe, per esistere e trasformarsi in mito e leggenda, ha bisogno di una narrazione: senza di essa, l'impresa resta nell'ombra, silenziosa e incompiuta," sottolinea Sabino Maria Frassà, Direttore Creativo di Cramum. Il Premio CIP-USSI, come spiega il Presidente del CIP Luca Pancalli, celebra e racconta "il valore dello sport come strumento di benessere e inclusione, capace di contribuire alla crescita culturale, sociale e civile del Paese". La medaglia è stata assegnata a numerosi giornalisti e comunicatori di spicco, tra cui Claudio Arrigoni, Novella Calligaris, Mattia Chiusano, Maria Luisa Colledani, Paolo De Laurentiis, Sandro Fioravanti, Giovanni Bruno, Claudio Lenzi, Nadia Lauricella, Dario Marchetti, Mirko Narducci, Mario Nicoliello, Roberto Pacchetti, Felicita Pistilli, Giacomo Prioreschi, Lorenzo Roata, Sonia Arpaia e Mauro Ujetto.Le Mostre Dedicata al Braille StellatoLe mostre sul Braille StellatoIl Braille Stellato, presentato per la prima volta nella mostra Romanitas presso lo spazio Gaggenau della capitale, è oggi protagonista della rassegna I limiti non esistono, nell'ambito dell'Olimpiade Culturale di Milano Cortina 2026. La rassegna, ideata da Sabino Maria Frassà, si sviluppa nei luoghi che saranno il cuore delle Paralimpiadi: Milano, Val di Fiemme e Cortina.Il primo appuntamento, Le stelle che non ti ho detto, si è tenuto nel 2025 presso il Museo d'Arte Contemporanea di Cavalese, aprendo il ciclo con una mostra co-curata dalla neo-direttrice Elsa Barbieri e dallo stesso Frassà. L'esposizione si è arricchita di performance dentro e fuori il Museo, alcune delle quali proseguiranno anche oltre la chiusura ufficiale della mostra, prevista per il 29 giugno 2025. In autunno, l'attenzione si sposta a Milano con la mostra LUDI – L'arte è un abbraccio, ospitata presso Palazzo Regione Lombardia. Al centro di questa esposizione vi è un inedito dialogo tra arte tattile e le sculture gonfiabili di Franco Mazzucchelli, incentrato sulla percezione sensoriale e sull'inclusione. La rassegna si concluderà con l'esposizione Cortina di Stelle al Lagazuoi Expo Dolomiti, il museo più alto delle Dolomiti. Qui, per la prima volta, verranno presentate le sculture luminose del ciclo Braillight, che combinano il Braille Stellato con la luce, creando un'esperienza immersiva a 2.732 metri di altitudine.IL POSTO DELLE PAROLEascoltare fa pensarewww.ilpostodelleparole.itDiventa un supporter di questo podcast: https://www.spreaker.com/podcast/il-posto-delle-parole--1487855/support.

Faith Part 6 "Unashamed Faith" Pastor Brad Gaillard March 16, 2025 by Tuscaloosa First Assembly

At the RNIB Inclusive Design For Sustainability Conference in Glasgow, Toby Davey caught up with Thibaut de Martimprey, Director, Campus Louis Braille and Stephane Gaillard, Director of the Institut National des Jeunes Aveugles (INJA) to find out more about the Campus Louis Braille and the importance of Braille as we talk about inclusive design. Image description: Exterior shot of the Glasgow Science Centre with its half-dome silver roof, glass front and the observation tower behind. At the front, a large video screen shows a pink background with white text: “RNIB Scotland, Inclusive Design for Sustainability, Conference.”

Andrew is joined by very special guest, neuroradiolgist Frank Gaillard, for a chat about posterior fossa tumours and his latest brain tumour course. Topics include ependymoma, choroid plexus papilloma,  medulloblastoma, pilocytic astrocytoma, haemangioblastoma and more!  Posterior Fossa Tumour Course ► https://radiopaedia.org/courses/posterior-fossa-tumours-learning-pathway Radiopaedia 2025 Virtual Conference ► https://radiopaedia.org/courses/radiopaedia-2025-virtual-conference Become a supporter ► https://radiopaedia.org/supporters Get an All-Access Pass ► https://radiopaedia.org/courses/all-access-course-pass Radiopaedia Community chat ► http://radiopaedia.org/chat Ideas and Feedback ► podcast@radiopaedia.org   The Reading Room is a radiology podcast intended primarily for radiologists, radiology registrars and residents. 

Faith Part 5 "Faith to Forgive" Pastor Brad Gaillard March 9, 2025 by Tuscaloosa First Assembly

The Hidden Dangers in Our Food and Water: A Deep Dive with Janet Benton GaillardIn this episode of the Roots to Riches podcast, I, Justin Benton, am thrilled to welcome back a very special guest and co-host from the Miracle Plant podcast days, my mom, Janet Benton Gaillard. Janet has been deeply immersed in writing a book that encapsulates her decades of work in health, and today she shares some of the invaluable insights she's gathered.We dive into the critical connection between health and wealth, emphasizing that true riches are unattainable without good health. Janet discusses the alarming rise in health issues among children in America over the past few decades, including neurological problems like ADHD and autism, as well as cancer and obesity. She highlights the importance of preventive measures and real solutions rather than temporary fixes.Janet introduces her upcoming book, "Safe Journey Through Childhood: Biohacks to Maintain Optimal Health," which aims to provide parents with actionable steps to ensure their children's health. We explore some of the book's key chapters, including the importance of an organic diet, limiting hard-to-digest and low-nutritional foods, and maintaining an alkaline over acidic diet. Janet also stresses the significance of drinking clean, distilled water and the detrimental effects of processed foods and environmental toxins.Throughout the episode, Janet shares her extensive background and credentials, from growing up in a healthy, organic environment to her advanced degrees in psychology and integrative nutrition. Her personal experiences with her family's health challenges further underscore her expertise and dedication to natural healing methods.We also touch on the broader issues of food and pharmaceutical industries, the impact of environmental toxins, and the importance of doing thorough research to make informed health decisions. Janet's holistic approach and practical advice offer listeners valuable guidance on improving their health and the health of their children. ASK THIS EPISODE ANYTHINGTIMESTAMPS00:00:00 - Introduction to the Podcast00:00:09 - Pharmaceutical Profits vs. Organic Foods00:00:43 - Welcome to the Miracle Plant Podcast00:01:02 - Introduction to Roots to Riches Podcast00:01:12 - Special Guest: Janet Benton Gaylord00:01:55 - Importance of Health for Wealth00:02:29 - Health Issues in Children00:03:01 - Book Title: Safe Journey Through Childhood00:03:43 - Increase in Health Issues Since the 1970s00:04:04 - Obesity and Cancer Crisis in America00:04:25 - Autism Epidemic00:05:08 - Comparative Health Data: US vs. Other Countries00:06:01 - Personal Connection to Autism00:06:22 - Biohack: Use of CBDA00:07:04 - Global Consultations on Autism00:07:18 - Janet's Background and Credentials00:08:05 - Growing Up Healthy in a Rural Family00:08:59 - Importance of Purpose and Community00:09:20 - Emphasis on Reading and Learning00:09:53 - Physical Activity and Organic Living00:10:25 - Academic Background and Degrees00:11:08 - Professional Experience with Autism and Developmental Delays00:12:44 - Integrative Nutrition and Herbal Medicine00:13:37 - Book Chapter: Eating an Organic Diet00:14:00 - Book Chapter: Limiting Hard-to-Digest Foods00:17:11 - Importance of Organic Foods00:19:00 - Processed Foods and Health00:23:29 - Book Chapter: Alkaline vs. Acidic Diets00:25:05 - Importance of pH Balance00:29:00 - Plant-Based Diet Benefits00:33:04 - Research and Transparency in Health00:35:04 - Pharmaceutical Influence on Food and Health00:37:27 - Book Chapter: Importance of Water00:39:01 - Contaminants in Water Supply00:41:07 - Benefits of Distilled Water00:43:05 - Daily Water Intake Recommendations00:45:10 - Water and Health00:47:01 - Fundamentals of Health: Water and Nutrition Thank you for tuning in to the Miracle Plant Podcast. Remember, our mission is to heal the world with the power of this miracle plant. Join us next time for more inspiring stories and insights into the world of cannabis. Produced by PodConx 101cbd - https://101cbd.org/Email Justin Benton - jbenton@101cbd.orgGet a free consultation - askjanet.orgKaneh Bosm Connection - https://youtube.com/@kanehbosmconnection

Today on Where Rodeo Meets the Road, we sit down with PRCA Saddle Bronc rookie Gus Gaillard to talk about his first year on the pro circuit. From the highs of big wins to the challenges of competing against the best in the world, Gus shares what it takes to make a name for yourself in one of rodeo's toughest events. We'll dive into his training, his mindset, and his goals for the season ahead. Don't miss this inside look at a rising star in rodeo!

Faith Part 4 - Steadfast Faith Pastor Brad Gaillard March 2, 2025 by Tuscaloosa First Assembly

Faith Part 3 "Faith That Takes the Leap" Pastor Brad Gaillard February 23, 2025 by Tuscaloosa First Assembly

Faith Part 2 "Beyond Sight" Pastor Brad Gaillard February 16, 2025 by Tuscaloosa First Assembly

"Faith Part 1 - I Believe But..." Pastor Brad Gaillard February 9, 2025 by Tuscaloosa First Assembly

Le 18 mars 2021, à la gendarmerie de Rennes, Jérôme Gaillard avoue : il a tué sa femme et mère de ses quatre enfants, Magali Blandin, un mois plus tôt. Le même jour, ses deux parents, Monique et Jean, sont aussi placés en garde à vue. Le couple est soupçonné d'avoir aidé leur fils à commettre son crime. Pourquoi ont-ils versé de l'argent à Jérôme ? Savaient-ils qu'il comptait embaucher des hommes de main ? Qu'il comptait tuer sa femme ? Après plusieurs jours passés en détention, les langues se délient et la vérité finit par éclater. La voix du crime de cet épisode présenté par Marie Zafimehy, c'est Maître Gwendoline Tenier, l'avocate de Monique Gaillard. Elle raconte comment sa cliente fut "la clé" de cette énigme, avant sa mort en février 2023.

"A Vision For The Church" Pastor Brad Gaillard February 2, 2025 by Tuscaloosa First Assembly

With America In Major New Administration & the Political News View Headlines Changing Everyday, This Book is Particularly Intriguing Now!!In 1974 John Egerton published his seminal work, The Americanization of Dixie. Pulitzer Prize-winner Cynthia Tucker and award-winning author Frye Gaillard carry Egerton's thesis forward in The Southernization of America, a compelling series of linked essays considering the role of the South in shaping America's current political and cultural landscape. They dive deeper, examining the morphing of the Southern strategy of Richard Nixon and Ronald Reagan into the Republican Party of today, the racial backlash against President Obama, family separation on our southern border, the rise of the Christian right, the white supremacist riots in Charlottesville, the death of George Floyd, and the attack on our nation's capitol. They find hope in the South too, a legacy rooted in the civil rights years that might ultimately lead the nation on the path to redemption. Tucker and Gaillard bring a multiracial perspective and years of political reporting to bear on a critical moment in American history, a time of racial reckoning and democracy under siege.Frye Gaillard is an award-winning journalist with over 30 published works on Southern history and culture, including Watermelon Wine; Cradle of Freedom: Alabama and the Movement that Changed America; The Books That Mattered: A Reader's Memoir; Journey to the Wilderness: War, Memory, and a Southern Family's Civil War Letters; Go South to Freedom; A Hard Rain: America in the 1960s, Our Decade of Hope, Possibility, and Innocence Lost; and The Slave Who Went to Congress. A Hard Rain was selected as one of NPR's Best Books of 2018. Writer-in-residence at the University of South Alabama, he is also John Egerton Scholar in Residence at the Southern Foodways Alliance at the University of Mississippi. He is the winner of the Clarence Cason Award for Nonfiction Writing, the Lillian Smith Book Award, and the Eugene Current-Garcia Award For Distinction in Literary Scholarship. In 2019, Gaillard was awarded the Alabama Governor's Arts Award for his contributions to literature.Cynthia Tucker is a Pulitzer Prize-winning syndicated columnist who has spent most of her career in journalism, having previously worked for the Atlanta Journal-Constitution as an editorial page editor and as a Washington-based political columnist. She has also been featured as a political commentator on television and radio. Tucker's work as a journalist has been celebrated by the National Association of Black Journalists (who inducted her into its hall of fame), Harvard University, and the Alabama Humanities Foundation. She spent three years as a visiting professor at the University of Georgia's Grady College of Journalism and is currently the journalist-in-residence at the University of South Alabama.© 2025 Building Abundant Success!!2025 All Rights ReservedJoin Me on ~ iHeart Media @ https://tinyurl.com/iHeartBASSpot Me on Spotify: https://tinyurl.com/yxuy23baAmazon Music ~ https://tinyurl.com/AmzBASAudacy:  https://tinyurl.com/BASAud

Dr. Stéphanie Gaillard and Dr. Bill Tew share updates to the evidence-based guideline on neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer. They highlight recommendations across ten clinical questions, addressing initial assessment, primary cytoreductive surgery, neoadjuvant chemotherapy (NACT), tests and/or procedures that should be completed before NACT, preferred chemotherapy regimens, timing of interval cytoreductive surgery (ICS), hyperthermic intraperitoneal chemotherapy (HIPEC), post ICS-chemotherapy, maintenance therapy, and options for those without a clinical response to NACT. They highlight the evidence supporting these recommendations and emphasize the importance of this guideline for clinicians and patients. Read the full guideline update, “Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update” at www.asco.org/gynecologic-cancer-guidelines." TRANSCRIPT This guideline, clinical tools, and resources are available at http://www.asco.org/genitourinary-cancer-guidelines. Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the Journal of Clinical Oncology. Brittany Harvey: Hello and welcome to the ASCO Guidelines podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges and advances in oncology. You can find all the shows, including this one at asco.org/podcasts. My name is Brittany Harvey and today I'm interviewing Dr. Stéphanie Gaillard from Johns Hopkins University and Dr. Bill Tew from Memorial Sloan Kettering Cancer Center, co-chairs on “Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.” Thank you for being here today, Dr. Gaillard and Dr. Tew. Dr. Bill Tew: Thank you for having us. Dr. Stéphanie Gaillard: Yeah, thank you. It's great to be here. Brittany Harvey: Great. Then, before we discuss this guideline, I'd like to note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO Conflict of Interest policy is followed for each guideline. The disclosures of potential conflicts of interest for the guideline panel, including Dr. Gaillard and Dr. Tew, who have joined us here today, are available online with the publication of the guideline in the Journal of Clinical Oncology, which is linked in the show notes. So then to dive into the content here, first, Dr. Tew, could you describe what prompted this update to the neoadjuvant chemotherapy for ovarian cancer guideline? And what is the scope of this update? Dr. Bill Tew: Yeah. It's been almost a decade since ASCO first published its neoadjuvant chemotherapy guidelines for women with newly diagnosed ovarian cancer, and over that 10-year period, there's really been a major shift in how oncologists treat patients in the U.S. If you look at the National Cancer Database, between 2010 and 2021, the proportion of patients with advanced ovarian cancer who underwent primary surgery fell from about 70% to about 37%. And there's been a doubling in the amount of neoadjuvant chemotherapy used. So we wanted to take a look at that and really both highlight the appropriate patient populations for primary surgery versus new adjuvant chemotherapy, as well as review any studies that have been published since then. There's been, I think, about 61 trials published, nine randomized trials alone in the last 10 years. And the scope of the guideline was really not only the neoadjuvant chemotherapy and surgical questions, but also to touch upon some new treatments that have come to the forefront in newly diagnosed ovarian cancer, including heated intraperitoneal chemotherapy or HIPEC, as well as the integration of maintenance therapy, particularly bevacizumab and PARP inhibitors. Brittany Harvey: Understood. That's a large amount of new evidence to review in this Update. Then, next, Dr. Gaillard, I'd like to review the key recommendations across the 10 clinical questions that the guideline addressed. So, starting with: What is recommended regarding initial assessment for patients with newly diagnosed pelvic masses and/or upper abdominal or peritoneal disease? Dr. Stéphanie Gaillard: Sure. So in talking about the first guidelines, the first one that we addressed was how to do the initial assessment for these patients. And first, and probably most critically, it's important to recognize that these patients really should be evaluated by a gynecologic oncologist prior to initiation of any therapy, whether that means a primary cytoreductive surgery or neoadjuvant chemotherapy, because really, they are the best ones to determine the pathway that the patient should take. The initial assessment should involve a CA-125, a CT of the abdomen and pelvis with oral and IV contrast, if not contraindicated, and then also chest imaging, in which a CT is really the preferred modality. And that helps to evaluate the extent of disease and the feasibility of the surgical resection. Now, there may be some other tools that could be helpful to also refine this assessment. So, for example, a laparoscopy can really help to determine the feasibility of surgical resection as well as the extent of disease. Further imaging, such as diffusion-weighted MRI or FDG-PET scans can be helpful, as well as ultrasounds. And then also an endometrial biopsy. And that was newly added because there really has been a divergence of treatment for endometrial cancer versus ovarian cancer. And so it's really important to determine upfront where the source of the disease is coming from. Brittany Harvey: I appreciate you describing those recommendations surrounding initial assessment. So following this assessment, Dr. Tew, which patients with newly diagnosed advanced epithelial ovarian cancer should be recommended primary cytoreductive surgery? Dr. Bill Tew: The key thing here is if the GYN oncology surgeon feels that they have a high likelihood of achieving a complete cytoreduction with acceptable morbidity, the panel overwhelmingly agrees that primary cytoreduction surgery should be recommended over chemotherapy. And we know that surgery is really the cornerstone to achieving clinical remission. And our concern is that neoadjuvant chemotherapy may be overused in this fit population. Sometimes it is challenging to determine truly if a patient has a high likelihood of complete cytoreduction or what is acceptable morbidity. But an evaluation with performance status, fitness, looking at age or frailty, nutritional status, as well as a review of imaging studies to plan and determine for who is the right patient for primary surgery is key. Brittany Harvey: And then the title of this guideline, Dr. Gaillard, for which patients is neoadjuvant chemotherapy recommended? Dr. Stéphanie Gaillard: Yeah. So there's really two patient populations that we think are best suited to receive neoadjuvant chemotherapy. Those may be patients who are fit for a primary cytoreductive surgery, but they're unlikely to have a complete cytoreduction if they were to go to surgery directly. And so that's where neoadjuvant chemotherapy can be very helpful in terms of increasing the ability to obtain a complete cytoreduction. The second population is those who are newly diagnosed who have a high perioperative risk, and so they're not fit to go to surgery directly. And so it may be better to start with neoadjuvant chemotherapy and then do an interval cytoreductive surgery. Again, I just want to emphasize the importance of including a gynecologic oncologist when making these determinations for patients. Brittany Harvey: Absolutely. So then the next clinical question. Dr. Tew, for those patients with newly diagnosed stage 3 to 4 epithelial ovarian cancer, what tests and or procedures are recommended before neoadjuvant chemotherapy is delivered? Dr. Bill Tew: The key test is to confirm the proper diagnosis, and that requires histological confirmation with a core biopsy. And this was a point the panel strongly emphasized, which is a core biopsy is a much better diagnostic tool compared to cytology alone. But there will be cases, exceptional cases, where a core biopsy cannot be performed. And in those settings, cytology combined with serum CA-125 and CEA is acceptable to exclude a non-gynecologic cancer. The other reason why cord biopsy is strongly preferred is because we already need to start thinking about germline and somatic testing for BRCA1 and 2. This information is important as we start to think about maintenance strategies for our patients. And so having that information early can help tailor the first-line chemotherapy regimen. Brittany Harvey: So then you've described who should be receiving neoadjuvant chemotherapy, but Dr. Gaillard, for those who are receiving neoadjuvant chemo, what is the preferred chemotherapy regimen? And then what does the expert panel recommend regarding timing of interval cytoreductive surgery? Dr. Stéphanie Gaillard: Sure. So for neoadjuvant chemotherapy, we generally recommend a platinum taxane doublet. This is especially important for patients with high grade serous or endometrioid ovarian cancers, and that's really because this is what the studies had used in the neoadjuvant trials. We recognize, however, that sometimes there are individual patient factors, such as advanced age or frailty, or certain disease factors such as the stage or rare histology that may shift what is used in terms of chemotherapy, but the recommendation is to try to stick as much as possible to the platinum taxane doublet. And then in terms of the timing of interval cytoreductive surgery, this was something that the panel discussed quite a bit and really felt that it should be performed after four or fewer cycles of neoadjuvant chemotherapy, especially in patients who've had a response to chemotherapy or stable disease. Sometimes alternative timing of surgery can be considered based on some patient centered factors, but those really haven't been prospectively evaluated. The studies that looked at neoadjuvant chemotherapy usually did the interval cytoreductive surgery after three or four cycles of chemotherapy. Brittany Harvey: For those patients who are receiving interval cytoreductive surgery, Dr. Tew, earlier in the podcast episode, you mentioned a new therapy. What is recommended regarding hyperthermic intraperitoneal chemotherapy? Dr. Bill Tew: Yeah, or simply HIPEC as everyone refers to it. You know, HIPEC isn't really a new therapy. HIPEC is a one-time perfusion of cisplatin, which is a chemotherapy that has been a standard treatment for ovarian cancer for decades. But the chemotherapy is heated and used as a wash during the interval cytoreductive surgery. And since our last guideline, there has been a publication of a randomized trial that looked at the use of HIPEC in this setting. And in that study there was improved disease-free and overall survival among the patients that underwent HIPEC versus those that did not. So we wanted to at least emphasize this data. But we also wanted to recognize that HIPEC may not be available at all sites. It's resource-intensive. It requires a patient to be medically fit for it, particularly renal function and performance status. And so it's something that could be discussed with the patient as an option in the interval cytoreductive surgery. One other point, the use of HIPEC during primary surgery or later lines of therapy still is unknown. And the other point is this HIPEC trial came prior to the introduction of maintenance PARP inhibitors. So there's still a lot of unknowns, but it is a reasonable option to discuss with appropriate patients. Brittany Harvey: I appreciate you reviewing that data and what that updated recommendation is from the panel. So then, Dr. Gaillard, after patients have received neoadjuvant chemotherapy and interval cytoreductive surgery, what is the post ICS chemotherapy recommended? Dr. Stéphanie Gaillard: The panel recommends some post ICS chemotherapy, as you mentioned. This is typically to continue the same chemotherapy that was done as neoadjuvant chemotherapy and so preferably platinum and taxane. And typically we recommend a total of six cycles of treatment, although the exact number of cycles that is given post-surgery can be adjusted based on different patient factors and their response to treatment. Importantly, also, timing is a factor, and we recommend that postoperative chemotherapy begin within four to six weeks after surgery, if at all feasible. Brittany Harvey: Absolutely. Those timing recommendations are key as well. So then, Dr. Tew, you mentioned this briefly earlier, but what is the role of maintenance therapy? Dr. Bill Tew: Maintenance therapy could be a full podcast plus of discussion, and it's complicated, but we did want to include it in this guideline in part because the determination of whether to continue treatment after completion of surgery and platinum based therapy is key as one is delivering care in the upfront setting. So first off, when we say maintenance therapy, we are typically referring to PARP inhibitors or bevacizumab. And I would refer listeners to the “ASCO PARP Inhibitor Guideline” that was updated about two years ago, as well as look at the FDA-approved label indications. But in general, PARP inhibitors, whether it's olaparib or niraparib, single agent or olaparib with bevacizumab, are standard treatments as maintenance, particularly in those patients with a germline or somatic BRCA mutation or those with an HRD score positive. And so it's really important that we emphasize germline and somatic BRCA testing for all patients with newly diagnosed ovarian cancer so that one can prepare for the use of maintenance therapy or not. And the other point is, as far as bevacizumab, bevacizumab is typically initiated during the chemotherapy section of first-line treatment. And in the guidelines we gave specific recommendations as far as when to start bevacizumab and in what patient population. Brittany Harvey: Great. Yes. And the PARP inhibitors guideline you mentioned is available on the ASCO guidelines website and we can provide a link in the show notes for our listeners. So then, the last clinical question, Dr. Gaillard, what treatment options are available for patients without a clinical response to neoadjuvant chemotherapy? Dr. Stéphanie Gaillard: Yeah, this is a tough situation. And so it's important to remember that ovarian cancer typically does respond to chemotherapy initially. And so it's unusual to have progressive disease to neoadjuvant chemotherapy. So it's really important that if someone has progressive disease that we question whether we really have the right diagnosis. And so it's important to, I think at that point, obtain another biopsy and make sure that we know what we're really dealing with. In addition, this is where Dr. Tew mentioned getting the molecular profiling and genetic testing early in the course of disease. If that hasn't been done at this point in time, it's worth doing that in this setting so that that can also potentially help guide options for patients. And patients who are in those situations, really, the options are other chemotherapy regimens, clinical trials may be an option, or in some situations, if they have really rapidly progressing disease that isn't amenable to further therapy, then initiation of end-of-life care would be appropriate. Brittany Harvey: I appreciate you both for reviewing all of these recommendations and options for patients with advanced ovarian cancer. So then to wrap us up, in your view, what is both the importance of this guideline update and how will it impact clinicians and patients with advanced ovarian cancer? Dr. Bill Tew: Well, first off, I'm very proud of this guideline and the panel that I work with and Dr. Gaillard, my co-chair. The guideline really pulls together nicely all the evidence in a simple format for oncologists to generate a plan and determine what's the best step for patients. The treatment of ovarian cancer, newly diagnosed, is really a team approach - surgeons, medical oncologists, and sometimes even general gynecologists - and understanding the data is key, as well as the advances in maintenance therapy and HIPEC. Dr. Stéphanie Gaillard: For my part, I'd say we hope that the update really provides physicians with best practice recommendations as they navigate neoadjuvant chemotherapy decisions for their patients who are newly diagnosed with ovarian cancer. There is a lot of data out there and so we hope that we've synthesized it in a way that makes it easier to digest. And along that regard, I really wanted to give a special shout out to Christina Lacchetti, who just put in a tremendous effort in putting these guidelines together and in helping to coordinate the panel. And so we really owe a lot to her in this effort. Dr. Bill Tew: Indeed. And ASCO, as always, helps guide and build a great resource for the oncology community. Brittany Harvey: Absolutely. Yes, we hope this is a useful tool for clinicians. And I want to thank you both for the large amount of work you put in to update this evidence-based guideline. And thank you for your time today, Dr. Gaillard and Dr. Tew. Dr. Stéphanie Gaillard: Thank you. Dr. Bill Tew: Thank you for having us. Brittany Harvey: And thank you to all of our listeners for tuning in to the ASCO Guidelines Podcast. To read the full guideline, go to www.asco.org/gynecologic-cancer-guidelines. You can also find many of our guidelines and interactive resources in the free ASCO Guidelines app, which is available in the Apple App Store or the Google Play Store. If you have enjoyed what you've heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode.   The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.  

Le 11 février 2021, Magali Blandin disparaît. Depuis deux mois cette mère de quatre enfants en instance de divorce vit à Montfort-sur-Meu près de Rennes. Pendant plusieurs semaines, tout le monde la cherche... y compris son mari Jérôme Gaillard. Pourtant, le 18 mars, il avoue : c'est lui qui a tué Magali. Il en a même parlé à ses parents, et voulu embaucher des hommes de mains - des "Géorgiens" - pour faire le sale boulot à sa place. Comment en est-il arrivé à fomenter un scénario aussi terrible ? La voix du crime de cet épisode présenté par Marie Zafimehy c'est Caryl Férey, auteur de "Magali" aux éditions Robert Laffont (2024). Il raconte son enquête sur ce féminicide qui a marqué la Bretagne par ses impensables ramifications et le profil du tueur, Jérôme Gaillard, aujourd'hui décédé.

"Servant Leadership" Nehemiah 7 Pastor Brad Gaillard January 19, 2025 by Tuscaloosa First Assembly

"Fearless Focus" Pastor Brad Gaillard January 12, 2025 by Tuscaloosa First Assembly

In the second of this two-part interview, author Frye Gaillard recalls the Jimmy Carter he knew and interviewed for two decades.

As the nation prepares to lay Jimmy Carter to rest, author Frye Gaillard recalls two decades of interviews with the former President.

"Rebuilding The Walls Of Justice" Pastor Brad Gaillard January 5, 2024 by Tuscaloosa First Assembly

"The Cost Of Courageous Leadership" Pastor Brad Gaillard December 29,2024 by Tuscaloosa First Assembly

Europe 1 Nuit revient sur la tragédie qui frappe Mayotte après le passage du cyclone Shiro. Avec un bilan provisoire de 22 morts et plus de 1 300 blessés, la situation reste critique. Alors que le président Macron prévoit une visite jeudi, le Premier ministre François Bayrou provoque une polémique en qualifiant Mayotte de « territoire étranger », suscitant l'indignation. Le député Perceval Gaillard appelle à une réponse urgente de l'État pour l'accès à l'eau potable et les soins. Notre équipe a utilisé un outil d'Intelligence artificielle via les technologies d'Audiomeans© pour accompagner la création de ce contenu écrit.

Tous les soirs, Pierre de Vilno reçoit un invité qui fait l'actualité politique. Ce soir, le député LFI de La Réunion, Perceval Gaillard qui reviendra notamment sur le déplacement controversé de François Bayrou à Pau plutôt que du côté de Mayotte complétement ravagé par le cyclone Chido.

"A Burden To Lead And A Heart To Hear" Nehemiah 1 Sermon Pastor Brad Gaillard 12:08:24 by Tuscaloosa First Assembly

"From Burden To Action" Nehemiah 2 Sermon Pastor Brad Gaillard 12:15:24 by Tuscaloosa First Assembly

In this episode of The Brand Called You, Rusty Gaillard an Executive Coach, discusses his journey from corporate leadership to coaching. He shares insights on how leaders can break free from traditional corporate norms, emphasising the importance of courage, authenticity, and personal growth. Rusty explains his coaching philosophy of helping high-achievers challenge the status quo, overcome the fear of failure, and redefine success beyond titles and salaries. He provides practical strategies for leaders to align personal values with professional roles, make impactful decisions, and prepare for a future of leadership that prioritizes human connection and relationship-building in an increasingly AI-driven workplace. About Rusty Gaillard Rusty Gaillard is an Executive Coach.  He joined Apple before the iPhone was launched and worked with Apple for 14 years before starting his coaching business.  Rusty has worked with individuals and teams in big tech to improve product reviews, executive communication, presentation skills, and time management. --- Support this podcast: https://podcasters.spotify.com/pod/show/tbcy/support

What started as a two-week pop-up experiment quickly grew into a global clean beauty revolution. In this episode of Where Brains Meet Beauty, we dive deep into the career journey of Romain Gaillard, Founder & CEO of The Detox Market. What began as a curiosity-driven concept soon blossomed into a movement that reshaped the beauty industry.Romain shares his 15-year journey of transforming The Detox Market from a space for discovery into a global brand recognized for its commitment to sustainability and innovation. From navigating the challenges of retail to making bold moves in e-commerce, he reflects on the lessons learned along the way. The brand's success was solidified when WWD named it one of the world's best concept stores, followed by expansion to six vibrant locations and a loyal customer base that has supported the brand from the start.While he reflects on the simplicity of those early days, Romain emphasizes the importance of growth, evolution, and resilience. Passion for his work has kept him going, but it's the power of strong teams and learning to take breaks that have allowed him to balance both life and business. With sustainability now at the forefront of consumer demand, Romain continues to tackle the challenge head-on, diving deep into product life cycles to reduce environmental impact.This episode offers a masterclass in perseverance, creativity, and innovation, with Romain's insights providing invaluable lessons for anyone navigating the fast-paced world of entrepreneurship and clean beauty.Don't forget to follow us @wherebrainsmeetbeautypodcast on Instagram for updates on new episodes and exclusive off-air content.

Das Parlament streitet in dieser Wintersession über das Budget fürs kommende Jahr. Wieso muss die Schweiz eigentlich so stark sparen? Serge Gaillard ist zu Gast im Tagesgespräch, er gilt als Chef-Sparer der Schweiz. Die Schweiz stehe vor grossen Auf- und Ausgaben: Die Aufstockung des Armeebudgets und die Finanzierung der 13. AHV-Rente sind nur zwei Beispiele. Der Bundesrat hat eine Arbeitsgruppe unter der Leitung von Serge Gaillard beauftragt, ein Sparpaket auszuarbeiten. 60 Massnahmen hat Gaillard vorgeschlagen, 5 Milliarden Franken könnten damit gespart werden. Aktuell geht es im Parlament um das Budget fürs kommende Jahr. Eine unheilige Allianz aus links und rechts könnte es bachab schicken. Das wäre historisch und ein Versagen des Parlaments, sagt Gaillard. Im Tagesgespräch erzählt er, warum der Spardruck aktuell so hoch ist, wie er auf der Suche nach Sparmöglichkeiten vorgegangen ist und wie die Bevölkerung die Massnahmen spüren würde. Serge Gaillard war bis 2021 Direktor der eidgenössischen Finanzverwaltung.

Le 18 mars 2021, à la gendarmerie de Rennes, Jérôme Gaillard avoue : il a tué sa femme et mère de ses quatre enfants, Magali Blandin, un mois plus tôt. Le même jour, ses deux parents, Monique et Jean, sont aussi placés en garde à vue. Le couple est soupçonné d'avoir aidé leur fils à commettre son crime. Pourquoi ont-ils versé de l'argent à Jérôme ? Savaient-ils qu'il comptait embaucher des hommes de main ? Qu'il comptait tuer sa femme ? Après plusieurs jours passés en détention, les langues se délient et la vérité finit par éclater. La voix du crime de cet épisode présenté par Marie Zafimehy, c'est Maître Gwendoline Tenier, l'avocate de Monique Gaillard. Elle raconte comment sa cliente fut "la clé" de cette énigme, avant sa mort en février 2023.

Le 11 février 2021, Magali Blandin disparaît. Depuis deux mois cette mère de quatre enfants en instance de divorce vit à Montfort-sur-Meu près de Rennes. Pendant plusieurs semaines, tout le monde la cherche... y compris son mari Jérôme Gaillard. Pourtant, le 18 mars, il avoue : c'est lui qui a tué Magali. Il en a même parlé à ses parents, et voulu embaucher des hommes de mains - des "Géorgiens" - pour faire le sale boulot à sa place. Comment en est-il arrivé à fomenter un scénario aussi terrible ? La voix du crime de cet épisode présenté par Marie Zafimehy c'est Caryl Férey, auteur de "Magali" aux éditions Robert Laffont (2024). Il raconte son enquête sur ce féminicide qui a marqué la Bretagne par ses impensables ramifications et le profil du tueur, Jérôme Gaillard, aujourd'hui décédé.

Faites un don et recevez un cadeau : http://don.storiavoce.com/ Qu'est-ce qui caractérise un esprit des Lumières appliqué à la couleur ? Le XVIIIe siècle est marqué par une révolution de la pensée. Ainsi, la manière de percevoir, de décrire et d'employer la couleur change. Une rupture s'opère avec les périodes antique et médiévale. Les découvertes de Newton, à travers l'expérience du prisme, apportent de nouvelles connaissances scientifiques, qui améliorent la compréhension du fonctionnement de la perception visuelle. La philosophie des Lumières conduit à une volonté de classifier, conceptualiser et mieux désigner les couleurs. De cette intention heuristique naît un véritable surgissement de la couleur dans les domaines de l'art, de la mode, de la littérature. Elle devient ainsi associée à l'expression du sentiment et adopte une fonction esthétique, qui diffère de la portée symbolique qui lui était attribuée aux époques antérieures. L'auteur : Aurélia Gaillard, professeur agrégée de littérature française du XVIIIe siècle à l'université Bordeaux-Montaigne, est autrice d'une thèse sur l'esthétique de la fable. Elle vient de publier un ouvrage illustré, intitulé L'Invention de la couleur par les Lumières. De Newton à Goethe, Belles Lettres, Paris, 325 p., 27 €. *** Facebook : https://www.facebook.com/HistoireEtCivilisationsMag Instagram : https://www.instagram.com/histoireetcivilisations/ Twitter : https://twitter.com/Storiavoce

Send us a textToday Vanessa & Heather interview Robyn Gaillard.Robyn Gaillard is a mind-body connection wellness educator & clinician. She is a passionate advocate for holistic wellness and the body's ability to heal.Today Robyn shares her personal pivotal experiences including healing a marathon training injury while running the race, understanding the "why" behind a skin cancer diagnosis, and holistically healing a thyroid dis-ease. Principles of circadian biology, looking to nature, and deep diving into mitochondrial health allowed Robyn to achieve wholeness, wellness, and a deep appreciation for life's ups and downs.Find Robyn herehttps://www.mywayom.com/Support the showFind Heather:https://www.instagram.com/heathercrimson/www.enlightenedmood.comDiscount codes:Viva Rays ➡️ Code: enlightenedmood.com for 10% offMidwest Red Light Therapy ➡️ Code: enlightenedmood for 10% offEMR-TEK ➡️ Code: HEATHER37030 for 20% offFind Vanessa:https://instagram.com/bright_light_wellness/vanessabaldwin/https://www.instagram.com/healingfamilieswithhomeopathy/Website: https://brightlightwellnesscoach.com/Discount codes:https://midwestredlighttherapy.com/ ➡️ Code: Brightlightwellnesshttps://vivarays.com/ ➡️ Code: BrightlightwellnessFree Product Guide http://gem.godaddy.com/signups/3cdbe47a101a4d2d9b991e9b5c9a981e/join Free Homeopathy Guide ...